Jennifer Lynett, PhD

Dr. Jennifer Lynett is the Technology Transfer Manager for the University Industry Liaison Office at the University of British Columbia. She is responsible for managing the technology portfolio at BC Children's Hospital and BC Women's Hospital + Health Centre.

Dr. Lynett’s research has focused on infectious diseases and immunology, and she completed her MSc at The University of Toronto before gaining her PhD from The University of British Columbia’s Department of Microbiology and Immunology. In providing technology transfer support for the Children’s & Women’s, Dr. Lynett evaluates and markets new inventions, negotiates with potential licensees and assists faculty in obtaining funding through the CIHR Proof of Principle program to commercialize their discovery.

Experience

Technology Transfer Manager, 2008-present
Technology Transfer Officer, UBC UILO, 2005-2008

Education & Training

BSc Microbiology & Immunology, UToronto; MSc Laboratory Medicine & Pathology, UToronto; PhD Microbiology & Immunology, UBC

Contact

Jennifer Lynett, PhD
Technology Transfer Manager
University of British Columbia
University Industry Liaison Office
103-6190 Agronomy Road
Vancouver, BC
Canada V6T 1Z3

Phone: 604-827-5351
Email: Jennifer.Lynett@uilo.ubc.ca

Get Involved

We need you today for a better tomorrow. Our kids are counting on it.

Get involved

Recent News See all

BCCHR research could help set new international standard for young children receiving bone marrow transplants

The findings from a BCCHR study played a part in integrating the multiple breath washout test into recent recommendations to screen children for pulmonary chronic graft-versus-host disease, a lung complication that can affect children who undergo a bone marrow transplant.

Continue reading BCCHR research could help set new international standard for young children receiving bone marrow transplants

Beyond access: Moving towards equity in pediatric type 1 diabetes care

Managing type 1 diabetes (T1D) can be challenging for patients, especially those from marginalized populations facing structural inequities. Families affected by T1D often grapple with managing a complex condition that requires continuous monitoring, timely insulin administration, and strict adherence to treatment plans. These challenges can be exacerbated for patients in socioeconomically deprived communities, where access to care and diabetes technology is often limited.

Continue reading Beyond access: Moving towards equity in pediatric type 1 diabetes care

New study makes key findings in potential advancement of diabetes cure

New research published in Nature Communications, identifies a key molecule that might be critical for the development of stem cell-based therapies for treating type 1 diabetes.

Continue reading New study makes key findings in potential advancement of diabetes cure

Pneumonia and malaria: Innovations tackle leading threats to children under five

Globally, pneumonia and malaria are among the leading causes of death for children under five, due in part to health-care resource gaps in low- and middle-income countries. New BCCHR investigator and pediatric infectious diseases expert Dr. Michael T. Hawkes is developing diagnostic and treatment tools to address these shortages.

Continue reading Pneumonia and malaria: Innovations tackle leading threats to children under five

Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Dr. Kirk Schultz, an investigator at BC Children’s Hospital Research Institute, has been awarded the 2024 Geoffrey L. Hammond Lectureship in recognition of his leadership and significant contributions to improving the health and well-being of children in British Columbia and around the world.

Continue reading Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Donate to Research

We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.

Give Now